Family Office Of America (FOFA) Cash & Equivalents Growth (1y) (2022 - 2026)
Family Office Of America (FOFA) Cash & Equivalents Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 72.43% |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | 8.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.28% |
| Dec 31, 2025 | 1,046.75% |
| Sep 30, 2025 | 1,672.01% |
| Jun 30, 2025 | 829.65% |
| Mar 31, 2025 | 524.07% |
| Dec 31, 2024 | 458.86% |
| Sep 30, 2024 | 3,408.94% |
| Jun 30, 2024 | 155.64% |
| Mar 31, 2024 | 462.38% |
| Dec 31, 2023 | -96.52% |
| Sep 30, 2023 | -99.23% |
| Jun 30, 2023 | -89.12% |
| Mar 31, 2023 | -95.96% |
| Dec 31, 2022 | -86.78% |
| Sep 30, 2022 | -75.57% |
| Jun 30, 2022 | -78.69% |